Navigation Links
Pitt researchers build a better mouse model to study depression
Date:5/18/2011

PITTSBURGH, May 19 - Researchers at the University of Pittsburgh School of Medicine have developed a mouse model of major depressive disorder (MDD) that is based on a rare genetic mutation that appears to cause MDD in the majority of people who inherit it. The findings, which were published online today in the American Journal of Medical Genetics Part B: Neuropsychiatric Genetics EarlyView, could help to clarify the brain events that lead to MDD, and contribute to the development of new and better means of treatment and prevention. This report also illustrates an advance in the design of recombinant mouse models that should be applicable to many human diseases.

"Major depressive disorder is a leading cause of suffering, disability and premature death from all causes including suicide. While the cause currently is unknown, twin and adoption studies indicate that genetic factors account for 40 to 70 percent of the risk for developing this common disorder," explained lead author George Zubenko, M.D., Ph.D., professor of psychiatry, Pitt School of Medicine.

"In this report, we describe how we constructed a laboratory mouse strain that mimics the brain mechanism that leads to major depression in humans, rather than symptoms," he said. "Nonetheless, in our initial characterization, the mutant mice exhibited several features that were reminiscent of the human disorder, including alterations of brain anatomy, gene expression, behavior, as well as increased infant mortality."

"These findings support the role of the genetic variant in the development of MDD, and affirm the mutant mouse strain as a model of MDD worthy of further study," Dr. Zubenko said. Hugh B. Hughes, III, M.S., served as the co-author of this report.

Previous studies of families with a severe and strongly familial form of MDD revealed a mutation in the control region of CREB1, a gene that orchestrates the expression of many other genes that play important roles in normal brain functioning. Mice have a CREB1 gene that is very similar to the human version and, with the aid of genetic engineering techniques, the researchers were able to establish a mutant mouse strain that bore the same genetic error. Since the control regions of corresponding human and mouse genes often have regions of high similarity, the methods described in this report may be useful in creating mouse models of other human diseases.

"Treatments that are the most effective and produce the fewest side effects typically address the root causes of the disease," Dr. Zubenko noted. "Animal models that recapitulate those root causes should better inform us about the brain mechanisms that lead to MDD, and have the best chance of leading to advances in treatment and prevention."


'/>"/>

Contact: Anita Srikameswaran
SrikamAV@upmc.edu
412-578-9193
University of Pittsburgh Schools of the Health Sciences
Source:Eurekalert

Related medicine news :

1. Researchers discover that lymphocyte count indicates prognosis of patients with renal cell carcinoma
2. Researchers home in on genetic signature of esophageal cancer
3. Legendary Hollywood directors and renowned researchers awarded 2011 Dan David Prizes
4. Columbia researchers work to prevent blindness from age-related macular degeneration
5. Hebrew University researchers show octopuses make some pretty good moves
6. Penn researchers identify the roots of memory impairment resulting from sleep deprivation
7. Researchers discover underlying mechanisms of skin hardening syndromes
8. Researchers examine procedure utilization trends in patients with clinically localized renal masses
9. Researchers identify DNA region linked to depression
10. Researchers move closer to identifying new class of asthma, COPD drugs
11. CWRU researchers call for changing how research is done
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2017)... ... 21, 2017 , ... Coffey Agencies, a full service insurance ... is embarking on an extended charity drive to encourage local residents to engage ... US Breast Cancer statistics show that over a quarter million new cases of ...
(Date:9/20/2017)... ... 20, 2017 , ... Reflections Recovery Center, a men-only drug ... Joint Commission for chemical dependency and behavioral health services. , The Joint Commission ... that meet the commission’s rigorous standards. Accreditation by The Joint Commission is the ...
(Date:9/20/2017)... ... September 20, 2017 , ... Collins Concrete Coatings announced ... that rely on safety and cleanliness. This unique flooring system uses silver ion ... used for centuries for its antimicrobial properties. Unlike antibiotics, which kill specific microorganisms, ...
(Date:9/20/2017)... ... September 20, 2017 , ... Renal Support ... people who have kidney disease. The theme “Describe a positive decision that you ... Entrants needed to meet only one qualification— to have been diagnosed with chronic ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... compliance and commercialization, has just released a new white paper discussing the ... adamant than ever about medical device, pharmaceutical, and combination product organizations making ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... , Sept. 8, 2017 ... Mobile MRI Unit coming to Washington DC ... When: Tuesday, September 12 th – Monday, September ... Washington, D.C. offering free MRI brain scans to the public.Where:  ... will be parked at 501 K Street NW, Washington, D.C.What:BTF brings its ...
(Date:9/7/2017)... , Sept. 7, 2017  Eli Lilly ... announced actions to streamline operations to more efficiently ... improve its cost structure. Global workforce reductions, including ... are expected to impact approximately 3,500 positions. ... company expects annualized savings of approximately $500 million ...
(Date:9/7/2017)... NuvoAir (formerly called Pond Healthcare Innovation), the company commercializing ... Pharma AG to distribute NuvoAir,s spirometry technology to physicians worldwide. ... platform and Novartis, commitment to address the unmet medical needs ... ... "We are ...
Breaking Medicine Technology: